Clinical Trial Update: Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effects of dapagliflozin and metformin on vascular function in newly diagnosed, treatment-naive type 2 diabetes patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• metformin (metformin)

Snippet

Sponsor: Tan Tock Seng Hospital | Conditions: Diabetes | Phase 4 | Status: UNKNOWN